Author:
Barton James C.,Barton J. Clayborn,Acton Ronald T.
Abstract
AbstractBackgroundHuman leukocyte antigen (HLA)-A*03, hemochromatosis ancestral haplotype marker, was associated with greater iron overload in hemochromatosis cohorts reported before discovery of theHFEgene. We sought to learn whether an A*03-linked locus influences phenotypes in referredHFEp.C282Y homozygotes.MethodsWe tabulated these phenotypes in probands with p.C282Y homozygosity: age, transferrin saturation (TS), serum ferritin (SF), conditions related to iron overload, fibrosis-four variables (FIB-4) index and aspartate aminotransferase-to-platelet ratio index (APRI) predictors of severe hepatic fibrosis, and iron removed to achieve depletion (QFe/age). We analyzed phenotypes of men and women separately across three A*03 subgroups.ResultsThere were 104 men (57.8%) and 76 women (42.2%). Mean age (SD) was 49 ± 13 y. Mean TS was 79 ± 17%. Median SF (range) was 715 µg/L (28, 6103). Related conditions included: hemochromatosis arthropathy (21.7%); type 2 diabetes (18.9%); hypogonadotropic hypogonadism (5.8% of men); cardiomyopathy (0%); and cirrhosis (10.0%). Median QFe/age was 61 mg/y (0, 714). A*03 homozygosity, heterozygosity, and no A*03 occurred in 37 (20.6%), 104 (57.8%), and 39 probands (21.7%), respectively. In men, mean TS and median SF were significantly higher in A*03 homozygotes than heterozygotes but not A*03-negative probands. In men, median APRI was significantly lower in A*03 heterozygotes than homozygotes and A*03-negative probands. No other phenotypes, including QFe/age, differed significantly across A*03 subgroups in either men or women.ConclusionsOur results suggest that an A*03-linked locus does not influence phenotypes in referredHFEp.C282Y homozygotes. It is unlikely that heritable factors that modify phenotypes of p.C282Y homozygotes are linked to the hemochromatosis ancestral haplotype.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,General Medicine
Reference75 articles.
1. Edwards CQ, Barton J.C. Hemochromatosis. In: Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, et al., editors. Wintrobe's Clinical Hematology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2014. p. 662–681.
2. Wood MJ, Powell LW, Ramm GA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood. 2008;111:4456–62.
3. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358:221–30.
4. Bodmer J, Bodmer WF, Payne R, Terasaki PI, Vredevoe D. Leucocyte antigens in man: a comparison of lymphocytotoxic and agglutination assays for their detection. Nature. 1966;210:28–31.
5. Walford R: First Meeting WHO Leukocyte Nomenclature Committee. New York, September, 1968. In: Terasaki PI, editor. History of HLA: Ten Recollections. Los Angeles: UCLA Tissue Typing Laboratory; 1990. p. 123–149.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献